Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Neoplasms of the CNS

  Free Subscription

Articles published in J Neurosurg

Retrieve available abstracts of 373 articles:
HTML format

Single Articles

    July 2021
  1. ASANO K, Hasegawa S, Matsuzaka M, Ohkuma H, et al
    Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data.
    J Neurosurg. 2021 Jul 16:1-12. doi: 10.3171/2020.11.JNS202873.
    PubMed     Abstract available

  2. NEMAN J, Franklin M, Madaj Z, Deshpande K, et al
    Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
    J Neurosurg. 2021 Jul 16:1-9. doi: 10.3171/2021.1.JNS203536.
    PubMed     Abstract available

  3. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    J Neurosurg. 2021 Jul 9:1-11. doi: 10.3171/2020.11.JNS202897.
    PubMed     Abstract available

  4. LI L, Fang S, Li G, Zhang K, et al
    Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
    J Neurosurg. 2021 Jul 9:1-9. doi: 10.3171/2020.12.JNS203351.
    PubMed     Abstract available

  5. CHAN AY, Choi EH, Oh MY, Vadera S, et al
    Elective versus nonelective brain tumor resections: a 5-year propensity score matching cost comparison analysis.
    J Neurosurg. 2021 Jul 9:1-5. doi: 10.3171/2020.12.JNS203401.
    PubMed     Abstract available

    June 2021
  6. ROSSI M, Puglisi G, Conti Nibali M, Vigano L, et al
    Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy.
    J Neurosurg. 2021 Jun 18:1-14. doi: 10.3171/2020.11.JNS202715.
    PubMed     Abstract available

  7. MOHAMMED N, Hung YC, Xu Z, Chytka T, et al
    Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery.
    J Neurosurg. 2021 Jun 18:1-6. doi: 10.3171/2020.12.JNS202814.
    PubMed     Abstract available

  8. KANEKO S, Suero Molina E, Sporns P, Schipmann S, et al
    Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    J Neurosurg. 2021 Jun 18:1-7. doi: 10.3171/2020.10.JNS202881.
    PubMed     Abstract available

  9. SHAH PP, Franke JL, Medikonda R, Jackson CM, et al
    Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
    J Neurosurg. 2021 Jun 4:1-11. doi: 10.3171/2020.10.JNS201787.
    PubMed     Abstract available

  10. DELLA PEPA GM, D'Alessandris QG, Burattini B, Quaranta D, et al
    Letter to the Editor. Exploring cognitive functions in low-grade glioma surgery.
    J Neurosurg. 2021 Jun 4:1-2. doi: 10.3171/2021.2.JNS21186.

  11. VIVAS-BUITRAGO T, Domingo RA, Tripathi S, De Biase G, et al
    Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    J Neurosurg. 2021 Jun 4:1-8. doi: 10.3171/2020.10.JNS203366.
    PubMed     Abstract available

    May 2021
  12. ROTH O'BRIEN DA, Kaye SM, Poppas PJ, Mahase SS, et al
    Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
    J Neurosurg. 2021 May 28:1-11. doi: 10.3171/2020.10.JNS201934.
    PubMed     Abstract available

  13. BABA A, Saha A, McCradden MD, Boparai K, et al
    Development and validation of a patient-centered, meningioma-specific quality-of-life questionnaire.
    J Neurosurg. 2021 May 14:1-10. doi: 10.3171/2020.11.JNS201761.
    PubMed     Abstract available

  14. QIAO N, Yang X, Li C, Ma G, et al
    The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma.
    J Neurosurg. 2021 May 7:1-11. doi: 10.3171/2020.10.JNS202779.
    PubMed     Abstract available

    March 2021
  15. FAN J, Liu Y, Pan J, Peng Y, et al
    Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients.
    J Neurosurg. 2021 Mar 5:1-12. doi: 10.3171/2020.7.JNS20257.
    PubMed     Abstract available

  16. MAGILL ST, Jane JA, Prevedello DM
    Editorial. Craniopharyngioma classification.
    J Neurosurg. 2021 Mar 5:1-3. doi: 10.3171/2020.8.JNS202666.

  17. FONSECA A, Solano P, Ramaswamy V, Tabori U, et al
    Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience.
    J Neurosurg. 2021 Mar 5:1-7. doi: 10.3171/2020.10.JNS203257.
    PubMed     Abstract available

  18. TENG CW, Cho SS, Singh Y, De Ravin E, et al
    Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery.
    J Neurosurg. 2021 Mar 2:1-10. doi: 10.3171/2020.8.JNS201810.
    PubMed     Abstract available

    February 2021
  19. MORISAKO H, Ohata H, Shinde B, Nagahama A, et al
    Minimal anterior and posterior combined transpetrosal approach for large petroclival meningiomas.
    J Neurosurg. 2021 Feb 19:1-10. doi: 10.3171/2020.8.JNS202060.
    PubMed     Abstract available

  20. RAPOPORT BI, McDermott MW, Schwartz TH
    Letter to the Editor. Time to move beyond the Simpson scale in meningioma surgery.
    J Neurosurg. 2021 Feb 19:1-2. doi: 10.3171/2020.12.JNS204213.

    January 2021
  21. MAGILL ST, Nguyen MP, Aghi MK, Theodosopoulos PV, et al
    Postoperative diffusion-weighted imaging and neurological outcome after convexity meningioma resection.
    J Neurosurg. 2021 Jan 29:1-8. doi: 10.3171/2020.8.JNS193537.
    PubMed     Abstract available

  22. MOTOMURA K, Chalise L, Shimizu H, Yamaguchi J, et al
    Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.
    J Neurosurg. 2021 Jan 22:1-10. doi: 10.3171/2020.8.JNS201400.
    PubMed     Abstract available

  23. YOUNG JS, Gogos AJ, Pereira MP, Morshed RA, et al
    Effects of ventricular entry on patient outcome during glioblastoma resection.
    J Neurosurg. 2021 Jan 8:1-9. doi: 10.3171/2020.7.JNS201362.
    PubMed     Abstract available

  24. BUNEVICIUS A, Suleiman M, Patel S, Martinez Alvarez R, et al
    Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study.
    J Neurosurg. 2021 Jan 1:1-9. doi: 10.3171/2020.7.JNS202064.
    PubMed     Abstract available

    December 2020
  25. STOGBAUER L, Thomas C, Wagner A, Warneke N, et al
    Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
    J Neurosurg. 2020 Dec 11:1-10. doi: 10.3171/2020.7.JNS193097.
    PubMed     Abstract available

  26. KENNEDY WR, DeWees TA, Acharya S, Mahmood M, et al
    Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2020 Dec 11:1-7. doi: 10.3171/2020.7.JNS192210.
    PubMed     Abstract available

  27. GUPTE TP, Li C, Jin L, Yalcin K, et al
    Clinical and genomic factors associated with seizures in meningiomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201042.
    PubMed     Abstract available

  28. NG S, Herbet G, Lemaitre AL, Cochereau J, et al
    Neuropsychological assessments before and after awake surgery for incidental low-grade gliomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201507.
    PubMed     Abstract available

    November 2020
  29. GOGOS AJ
    Erratum. Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Nov 27:1. doi: 10.3171/2020.10.JNS193434.

  30. YOO DH, Sohn CH, Cho YD, Kang HS, et al
    Superselective pseudocontinuous arterial spin labeling in patients with meningioma: utility in prediction of feeding arteries and preoperative embolization feasibility.
    J Neurosurg. 2020 Nov 13:1-7. doi: 10.3171/2020.7.JNS201915.
    PubMed     Abstract available

  31. MIYOSHI K, Wada T, Uwano I, Sasaki M, et al
    Predicting the consistency of intracranial meningiomas using apparent diffusion coefficient maps derived from preoperative diffusion-weighted imaging.
    J Neurosurg. 2020 Nov 13:1-8. doi: 10.3171/2020.6.JNS20740.
    PubMed     Abstract available

    October 2020
  32. PRZYBYLOWSKI CJ, Hendricks BK, Frisoli FA, Zhao X, et al
    Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.
    J Neurosurg. 2020 Oct 23:1-9. doi: 10.3171/2020.6.JNS20374.
    PubMed     Abstract available

  33. CHICOINE MR, Yahanda AT, Dacey RG
    A tribute to the late Professor Donald Simpson, Australian neurosurgeon and namesake of the Simpson grading system for meningioma extent of resection.
    J Neurosurg. 2020 Oct 23:1-7. doi: 10.3171/2020.6.JNS201331.
    PubMed     Abstract available

  34. SHAH AS, Sylvester PT, Yahanda AT, Vellimana AK, et al
    Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    J Neurosurg. 2020 Oct 9:1-10. doi: 10.3171/2020.6.JNS19287.
    PubMed     Abstract available

  35. SELLIER A, Moritz-Gasser S, Lemaitre AL, Herbet G, et al
    Presence of a translator in the operating theater for awake mapping in foreign patients with low-grade glioma: a surgical experience based on 18 different native languages.
    J Neurosurg. 2020 Oct 9:1-9. doi: 10.3171/2020.6.JNS201071.
    PubMed     Abstract available

  36. GOGOS AJ, Young JS, Pereira MP, Morshed RA, et al
    Surgical management of incidentally discovered low-grade gliomas.
    J Neurosurg. 2020 Oct 2:1-8. doi: 10.3171/2020.6.JNS201296.
    PubMed     Abstract available

  37. LIVERMORE LJ, Isabelle M, Bell IM, Edgar O, et al
    Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery.
    J Neurosurg. 2020 Oct 2:1-11. doi: 10.3171/2020.5.JNS20376.
    PubMed     Abstract available

    September 2020
  38. NAVARRIA P, Pessina F, Clerici E, Rossini Z, et al
    Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
    J Neurosurg. 2020 Sep 4:1-14. doi: 10.3171/2020.5.JNS201116.
    PubMed     Abstract available

    August 2020
  39. WANG L, Chen J
    Letter to the Editor. Feasibility and safety of supratotal resection for low-grade gliomas.
    J Neurosurg. 2020 Aug 28:1-2. doi: 10.3171/2020.7.JNS202601.

  40. KHALAFALLAH AM, Huq S, Jimenez AE, Brem H, et al
    The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients.
    J Neurosurg. 2020 Aug 14:1-9. doi: 10.3171/2020.5.JNS20766.
    PubMed     Abstract available

    July 2020
  41. STRICKLAND BA, Wedemeyer M, Sizdahkhani S, Giannotta SL, et al
    Letter to the Editor. Management of petroclival meningioma.
    J Neurosurg. 2020 Jul 31:1-3. doi: 10.3171/2020.3.JNS20599.

  42. YOUNGERMAN BE, Banu MA, Gerges MM, Odigie E, et al
    Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data.
    J Neurosurg. 2020 Jul 24:1-13. doi: 10.3171/2020.4.JNS20475.
    PubMed     Abstract available

  43. FUKUI N, Yawata T, Nakajo T, Kawanishi Y, et al
    Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    J Neurosurg. 2020 Jul 24:1-11. doi: 10.3171/2020.4.JNS193078.
    PubMed     Abstract available

  44. SPILLE DC, Hess K, Bormann E, Sauerland C, et al
    Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification.
    J Neurosurg. 2020 Jul 17:1-8. doi: 10.3171/2020.4.JNS20412.
    PubMed     Abstract available

  45. BUNEVICIUS A, Lavezzo K, Shabo L, McClure J, et al
    Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2020 Jul 10:1-9. doi: 10.3171/2020.4.JNS20788.
    PubMed     Abstract available

    June 2020
  46. ANSARI A
    Letter to the Editor. Awake craniotomy and transcortical MEP monitoring for resection of precentral gliomas.
    J Neurosurg. 2020 Jun 12:1-2. doi: 10.3171/2020.4.JNS201190.

    Erratum. Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jun 12:1. doi: 10.3171/2020.5.JNS192466.

  48. SUI R, Piao H
    Letter to the Editor. Residual meningiomas.
    J Neurosurg. 2020 Jun 12:1-3. doi: 10.3171/2020.2.JNS20447.

  49. GOGOS AJ, Young JS, Morshed RA, Avalos LN, et al
    Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Jun 5:1-10. doi: 10.3171/2020.3.JNS193434.
    PubMed     Abstract available

  50. GARTON ALA, Kinslow CJ, Wang TJC
    Erratum. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 Jun 5:1. doi: 10.3171/2020.5.JNS192767.

  51. KONG DS, Kim YH, Hong CK
    Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas.
    J Neurosurg. 2020 Jun 5:1-8. doi: 10.3171/2020.3.JNS20297.
    PubMed     Abstract available

    May 2020
  52. ABI JAOUDE S, Peyre M, Degos V, Goutagny S, et al
    Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    J Neurosurg. 2020 May 22:1-9. doi: 10.3171/2020.3.JNS192382.
    PubMed     Abstract available

  53. JULIE DA, Lazow SP, Vanderbilt DB, Taube S, et al
    A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    J Neurosurg. 2020 May 15:1-8. doi: 10.3171/2020.3.JNS193419.
    PubMed     Abstract available

  54. FATIMA N, Ding VY, Han SS, Chang SD, et al
    Predictors of visual functional outcome following treatment for cavernous sinus meningioma.
    J Neurosurg. 2020 May 15:1-12. doi: 10.3171/2020.2.JNS193009.
    PubMed     Abstract available

  55. BOWDEN GN, Kim JO, Faramand A, Fallon K, et al
    Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
    J Neurosurg. 2020 May 8:1-5. doi: 10.3171/2020.3.JNS193369.
    PubMed     Abstract available

  56. GARTON ALA, Kinslow CJ, Rae AI, Mehta A, et al
    Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 May 8:1-11. doi: 10.3171/2020.2.JNS192767.
    PubMed     Abstract available

  57. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Correlation between localization of supratentorial glioma to the precentral gyrus and difficulty in identification of the motor area during awake craniotomy.
    J Neurosurg. 2020 May 1:1-10. doi: 10.3171/2020.2.JNS193471.
    PubMed     Abstract available

  58. MIRCHANDANI AS, Beyh A, Lavrador JP, Howells H, et al
    Altered corticospinal microstructure and motor cortex excitability in gliomas: an advanced tractography and transcranial magnetic stimulation study.
    J Neurosurg. 2020 May 1:1-9. doi: 10.3171/2020.2.JNS192994.
    PubMed     Abstract available

    April 2020
  59. DE VRIES F
    Letter to the Editor. Cognitive performance of patients with low-grade glioma.
    J Neurosurg. 2020 Apr 24:1-2. doi: 10.3171/2020.1.JNS2097.

  60. LEE AT, Faltermeier C, Morshed RA, Young JS, et al
    The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS192267.
    PubMed     Abstract available

  61. CHU S
    Erratum. Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2020 Apr 3:1. doi: 10.3171/2020.2.JNS191920.

  62. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    Quantifying eloquent locations for glioblastoma surgery using resection probability maps.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS193049.
    PubMed     Abstract available

    March 2020
  63. PRZYBYLOWSKI CJ, Zhao X, Baranoski JF, Borba Moreira L, et al
    Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study.
    J Neurosurg. 2020 Mar 27:1-8. doi: 10.3171/2020.1.JNS19788.
    PubMed     Abstract available

  64. ZANELLO M, Roux A, Zah-Bi G, Trancart B, et al
    Predictors of early postoperative epileptic seizures after awake surgery in supratentorial diffuse gliomas.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2020.1.JNS192774.
    PubMed     Abstract available

  65. YAMADA T, Tsuji S, Nakamura S, Egashira Y, et al
    Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2019.12.JNS192682.
    PubMed     Abstract available

  66. DALLE ORE CL, Magill ST, Rodriguez Rubio R, Shahin MN, et al
    Hyperostosing sphenoid wing meningiomas: surgical outcomes and strategy for bone resection and multidisciplinary orbital reconstruction.
    J Neurosurg. 2020 Mar 6:1-10. doi: 10.3171/2019.12.JNS192543.
    PubMed     Abstract available

    February 2020
  67. GOLUB D, Hyde J, Dogra S, Nicholson J, et al
    Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis.
    J Neurosurg. 2020 Feb 21:1-15. doi: 10.3171/2019.12.JNS191203.
    PubMed     Abstract available

  68. ISHI Y, Yamaguchi S, Hatanaka KC, Okamoto M, et al
    Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    J Neurosurg. 2020 Feb 14:1-9. doi: 10.3171/2019.12.JNS192155.
    PubMed     Abstract available

  69. YAMASHITA D, Bernstock JD, Elsayed G, Sadahiro H, et al
    Targeting glioma-initiating cells via the tyrosine metabolic pathway.
    J Neurosurg. 2020 Feb 14:1-12. doi: 10.3171/2019.11.JNS192028.
    PubMed     Abstract available

    January 2020
  70. SUERO MOLINA E, Brokinkel B
    Letter to the Editor. Sodium fluorescein versus 5-aminolevulinic acid to visualize high-grade gliomas.
    J Neurosurg. 2020 Jan 24:1-3. doi: 10.3171/2019.12.JNS193180.

  71. SCHIPMANN S, Muther M, Stogbauer L, Zimmer S, et al
    Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.
    J Neurosurg. 2020 Jan 24:1-11. doi: 10.3171/2019.11.JNS192443.
    PubMed     Abstract available

  72. PRIETO R, Pascual JM
    Cushing's dogged struggle against death: the astonishing case of a patient under cardiac arrest surviving craniopharyngioma surgery.
    J Neurosurg. 2020 Jan 17:1-10. doi: 10.3171/2019.11.JNS192487.
    PubMed     Abstract available

  73. LIU D, Chen J, Hu X, Hu G, et al
    Contralesional homotopic functional plasticity in patients with temporal glioma.
    J Neurosurg. 2020 Jan 10:1-9. doi: 10.3171/2019.11.JNS191982.
    PubMed     Abstract available

  74. MATERI J, Mampre D, Ehresman J, Rincon-Torroella J, et al
    Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jan 3:1-7. doi: 10.3171/2019.10.JNS192466.
    PubMed     Abstract available

  75. PARK SH, Kim MJ, Jung HH, Chang WS, et al
    Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy.
    J Neurosurg. 2020 Jan 3:1-9. doi: 10.3171/2019.10.JNS192206.
    PubMed     Abstract available

    December 2019
  76. BERGER A, Tzarfati G, Costa M, Serafimova M, et al
    Incidence and impact of stroke following surgery for low-grade gliomas.
    J Neurosurg. 2019 Dec 27:1-9. doi: 10.3171/2019.10.JNS192301.
    PubMed     Abstract available

  77. RUSTEMI O, Raneri F, Beggio G, Volpin L, et al
    Letter to the Editor. Cost-effectiveness of sodium fluorescein in high-grade gliomas.
    J Neurosurg. 2019 Dec 13:1-2. doi: 10.3171/2019.10.JNS192817.

  78. ARRIETA VA, Iwamoto F, Lukas RV, Sachdev S, et al
    Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
    J Neurosurg. 2019 Dec 6:1-6. doi: 10.3171/2019.9.JNS192523.

    November 2019
  79. TULEASCA C, Giammattei L, Daniel RT, Levivier M, et al
    Letter to the Editor. Multimodal management for benign skull base meningiomas.
    J Neurosurg. 2019 Nov 15:1-2. doi: 10.3171/2019.6.JNS191682.

  80. QIU T, Chanchotisatien A, Qin Z, Wu J, et al
    Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2019 Nov 15:1-9. doi: 10.3171/2019.9.JNS191920.
    PubMed     Abstract available

  81. RIJNEN SJM, Kaya G, Gehring K, Verheul JB, et al
    Cognitive functioning in patients with low-grade glioma: effects of hemispheric tumor location and surgical procedure.
    J Neurosurg. 2019 Nov 15:1-12. doi: 10.3171/2019.8.JNS191667.
    PubMed     Abstract available

  82. PRIETO R, Pascual JM, Barrios L
    Charles H. Frazier's craniopharyngioma treatment: the pivotal role of the transfrontal approach.
    J Neurosurg. 2019 Nov 8:1-14. doi: 10.3171/2019.8.JNS191508.
    PubMed     Abstract available

  83. BERNSTEIN A, Mrowczynski OD, Greene A, Ryan S, et al
    Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.
    J Neurosurg. 2019 Nov 1:1-6. doi: 10.3171/2019.8.JNS19643.
    PubMed     Abstract available

  84. PRIETO R, Pascual JM
    Letter to the Editor. The craniopharyngioma-hypothalamus relationship.
    J Neurosurg. 2019 Nov 1:1-2. doi: 10.3171/2019.7.JNS191780.

    October 2019
    Editorial. Considering the role of surgery for low-grade glioma in the molecular genetic era.
    J Neurosurg. 2019 Oct 25:1-3. doi: 10.3171/2019.7.JNS191747.

  86. KAVOURIDIS VK, Boaro A, Dorr J, Cho EY, et al
    Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.
    J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.6.JNS19972.
    PubMed     Abstract available

  87. YOUNGBLOOD MW, Duran D, Montejo JD, Li C, et al
    Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
    J Neurosurg. 2019 Oct 25:1-10. doi: 10.3171/2019.8.JNS191266.
    PubMed     Abstract available

  88. SMITH N, Saunders D, Jensen RL, Towner RA, et al
    Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS182435.
    PubMed     Abstract available

  89. YOMO S, Oda K, Oguchi K
    Single- versus 2-session Gamma Knife surgery for symptomatic midsize brain metastases: a propensity score-matched analysis.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS191193.
    PubMed     Abstract available

  90. IBRAHIM AN, Yamashita D, Anderson JC, Abdelrashid M, et al
    Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.
    J Neurosurg. 2019 Oct 18:1-12. doi: 10.3171/2019.7.JNS191376.
    PubMed     Abstract available

  91. SCHNEIDER M, Guresir A, Borger V, Hamed M, et al
    Preoperative tumor-associated epilepsy in patients with supratentorial meningioma: factors influencing seizure outcome after meningioma surgery.
    J Neurosurg. 2019 Oct 11:1-7. doi: 10.3171/2019.7.JNS19455.
    PubMed     Abstract available

  92. HANSEN RW, Pedersen CB, Halle B, Korshoej AR, et al
    Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.
    J Neurosurg. 2019 Oct 4:1-8. doi: 10.3171/2019.6.JNS191531.
    PubMed     Abstract available

  93. JARVIS CA, Bakhsheshian J, Ding L, Wen T, et al
    Increased complication and mortality among non-index hospital readmissions after brain tumor resection is associated with low-volume readmitting hospitals.
    J Neurosurg. 2019 Oct 4:1-13. doi: 10.3171/2019.6.JNS183469.
    PubMed     Abstract available

    September 2019
  94. MARHOLD F, Mercea PA, Scheichel F, Berghoff AS, et al
    Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers: experience in 157 cases.
    J Neurosurg. 2019 Sep 27:1-12. doi: 10.3171/2019.6.JNS1997.
    PubMed     Abstract available

  95. ZHU P, Du XL, Blanco AI, Ballester LY, et al
    Impact of facility type and volume in low-grade glioma outcomes.
    J Neurosurg. 2019 Sep 27:1-11. doi: 10.3171/2019.6.JNS19409.
    PubMed     Abstract available

  96. FECCI PE, Sampson JH
    The current state of immunotherapy for gliomas: an eye toward the future.
    J Neurosurg. 2019;131:657-666.
    PubMed     Abstract available

    August 2019
  97. WANG CH, Qi ST, Fan J, Pan J, et al
    Identification of tumor stem-like cells in admanatimomatous craniopharyngioma and determination of these cells' pathological significance.
    J Neurosurg. 2019 Aug 30:1-11. doi: 10.3171/2019.5.JNS19565.
    PubMed     Abstract available

  98. LAVRADOR JP, Ghimire P, Gullan R, Ashkan K, et al
    Letter to the Editor. Insular glioma surgery.
    J Neurosurg. 2019 Aug 30:1-2. doi: 10.3171/2019.4.JNS19760.

  99. KIYOFUJI S, Casabella AM, Graffeo CS, Perry A, et al
    Sphenoorbital meningioma: a unique skull base tumor. Surgical technique and results.
    J Neurosurg. 2019 Aug 23:1-8. doi: 10.3171/2019.6.JNS191158.
    PubMed     Abstract available

  100. BERNSTOCK JD, Mooney JH, Ilyas A, Chagoya G, et al
    Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications.
    J Neurosurg. 2019 Aug 23:1-9. doi: 10.3171/2019.5.JNS19364.
    PubMed     Abstract available

  101. DEORA H, Das KK, Jaiswal A, Behari S, et al
    Letter to the Editor. Tumor extension determines approach in insular gliomas.
    J Neurosurg. 2019 Aug 23:1-2. doi: 10.3171/2019.5.JNS191308.

  102. TAKEI H, Shinoda J, Ikuta S, Maruyama T, et al
    Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.
    J Neurosurg. 2019 Aug 16:1-10. doi: 10.3171/2019.5.JNS19780.
    PubMed     Abstract available

  103. KIM KH, Kong DS, Cho KR, Lee MH, et al
    Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study.
    J Neurosurg. 2019 Aug 16:1-10. doi: 10.3171/2019.5.JNS19222.
    PubMed     Abstract available

  104. INCEKARA F, Smits M, Vincent AJPE
    Letter to the Editor. Supratotal resection of glioblastoma.
    J Neurosurg. 2019 Aug 16:1-2. doi: 10.3171/2019.3.JNS19810.

  105. BUTOWSKI NA, Bringas JR, Bankiewicz KS, Aghi MK, et al
    Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma.
    J Neurosurg. 2019 Aug 2:1-3. doi: 10.3171/2019.4.JNS19614.

  106. ZHAO X, Belykh E, Przybylowski CJ, Borba Moreira L, et al
    Surgical treatment of falcotentorial meningiomas: a retrospective review of a single-institution experience.
    J Neurosurg. 2019 Aug 2:1-12. doi: 10.3171/2019.4.JNS19208.
    PubMed     Abstract available

    July 2019
  107. CAPLAN IF, Glauser G, Goodrich S, Chen HI, et al
    Undiagnosed obstructive sleep apnea as a predictor of 30-day readmission for brain tumor patients.
    J Neurosurg. 2019 Jul 19:1-6. doi: 10.3171/2019.4.JNS1968.
    PubMed     Abstract available

  108. PALA A, Coburger J, Scherer M, Ahmeti H, et al
    To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatment.
    J Neurosurg. 2019 Jul 19:1-8. doi: 10.3171/2019.4.JNS183395.
    PubMed     Abstract available

  109. PRIETO R, Pascual JM
    Letter to the Editor. Heterogeneous hypothalamic adhesion among third ventricle craniopharyngiomas.
    J Neurosurg. 2019 Jul 19:1-2. doi: 10.3171/2019.3.JNS19755.

    June 2019
  110. JENKINSON MD, Ali A, Islim AI, Helmy A, et al
    Letter to the Editor. Establishing the role of prophylactic antiepileptic drugs in glioma and meningioma surgery.
    J Neurosurg. 2019 Jun 28:1-3. doi: 10.3171/2019.1.JNS19134.

  111. LEE CC, Hsu SPC, Lin CJ, Wu HM, et al
    Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non-small cell lung cancer and brain metastases.
    J Neurosurg. 2019 Jun 21:1-8. doi: 10.3171/2019.4.JNS19446.
    PubMed     Abstract available

  112. BUTSCHEIDT S, Ernst M, Rolvien T, Hubert J, et al
    Primary intraosseous meningioma: clinical, histological, and differential diagnostic aspects.
    J Neurosurg. 2019 Jun 21:1-10. doi: 10.3171/2019.3.JNS182968.
    PubMed     Abstract available

  113. CHANDRA A, Young JS, Dalle Ore C, Dayani F, et al
    Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma.
    J Neurosurg. 2019 Jun 21:1-11. doi: 10.3171/2019.3.JNS182629.
    PubMed     Abstract available

  114. HAAPALA I, Karjalainen M, Kontunen A, Vehkaoja A, et al
    Identifying brain tumors by differential mobility spectrometry analysis of diathermy smoke.
    J Neurosurg. 2019 Jun 14:1-7. doi: 10.3171/2019.3.JNS19274.
    PubMed     Abstract available

  115. RAFFA G, Picht T, Scibilia A, Rosler J, et al
    Surgical treatment of meningiomas located in the rolandic area: the role of navigated transcranial magnetic stimulation for preoperative planning, surgical strategy, and prediction of arachnoidal cleavage and motor outcome.
    J Neurosurg. 2019 Jun 14:1-12. doi: 10.3171/2019.3.JNS183411.
    PubMed     Abstract available

  116. PRIETO R, Pascual JM
    Percival S. Bailey: eminent scholar of neurosciences who revealed the workings of the hypothalamus through clinicopathological research on craniopharyngiomas.
    J Neurosurg. 2019 Jun 14:1-13. doi: 10.3171/2019.3.JNS183145.
    PubMed     Abstract available

  117. TANG B, Xie S, Huang G, Wang Z, et al
    Clinical features and operative technique of transinfundibular craniopharyngioma.
    J Neurosurg. 2019 Jun 14:1-10. doi: 10.3171/2019.3.JNS181953.
    PubMed     Abstract available

  118. TERPOLILLI NA, Ueberschaer M, Niyazi M, Hintschich C, et al
    Long-term outcome in orbital meningiomas: progression-free survival after targeted resection combined with early or postponed postoperative radiotherapy.
    J Neurosurg. 2019 Jun 14:1-11. doi: 10.3171/2019.3.JNS181760.
    PubMed     Abstract available

    May 2019
  119. ALMIRON BONNIN DA, Havrda MC, Lee MC, Evans L, et al
    Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma.
    J Neurosurg. 2019 May 24:1-9. doi: 10.3171/2019.2.JNS183128.
    PubMed     Abstract available

  120. KIM JH, Moon KS, Jung JH, Jang WY, et al
    Importance of collateral venous circulation on indocyanine green videoangiography in intracranial meningioma resection: direct evidence for venous compression theory in peritumoral edema formation.
    J Neurosurg. 2019 May 24:1-9. doi: 10.3171/2019.3.JNS182308.
    PubMed     Abstract available

  121. MOTOMURA K, Chalise L, Ohka F, Aoki K, et al
    Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping.
    J Neurosurg. 2019 May 17:1-9. doi: 10.3171/2019.3.JNS19211.
    PubMed     Abstract available

  122. ROSSI M, Ambrogi F, Gay L, Gallucci M, et al
    Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome.
    J Neurosurg. 2019 May 17:1-14. doi: 10.3171/2019.2.JNS183408.
    PubMed     Abstract available

  123. GUO X, Yao S, Xing B
    Letter to the Editor. Is 7-Tesla MRI necessary in the assessment of microstructural injury to visual pathways due to pituitary adenomas?
    J Neurosurg. 2019 May 17:1-3. doi: 10.3171/2019.2.JNS19413.

  124. KIM JW, Jung HW, Kim YH, Park CK, et al
    Petroclival meningiomas: long-term outcomes of multimodal treatments and management strategies based on 30 years of experience at a single institution.
    J Neurosurg. 2019 May 10:1-8. doi: 10.3171/2019.2.JNS182604.
    PubMed     Abstract available

  125. WIDHALM G, Olson J, Weller J, Bravo J, et al
    The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
    J Neurosurg. 2019 May 10:1-10. doi: 10.3171/2019.1.JNS182614.
    PubMed     Abstract available

    April 2019
  126. SUERO MOLINA E, Ewelt C, Warneke N, Schwake M, et al
    Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note.
    J Neurosurg. 2019 Apr 26:1-7. doi: 10.3171/2018.12.JNS182422.
    PubMed     Abstract available

  127. SERIZAWA T, Yamamoto M, Higuchi Y, Sato Y, et al
    Local tumor progression treated with Gamma Knife radiosurgery: differences between patients with 2-4 versus 5-10 brain metastases based on an update of a multi-institutional prospective observational study (JLGK0901).
    J Neurosurg. 2019 Apr 26:1-10. doi: 10.3171/2019.1.JNS183085.
    PubMed     Abstract available

  128. LI C, Wang S, Yan JL, Torheim T, et al
    Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging.
    J Neurosurg. 2019 Apr 26:1-8. doi: 10.3171/2018.12.JNS182926.
    PubMed     Abstract available

  129. GUPTA N
    Editorial. Patient outcomes following treatment for craniopharyngioma.
    J Neurosurg. 2019 Apr 19:1-2. doi: 10.3171/2018.12.JNS182943.

  130. LAN F, Qin Q, Yu H, Yue X, et al
    Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity.
    J Neurosurg. 2019 Apr 19:1-9. doi: 10.3171/2018.12.JNS181798.
    PubMed     Abstract available

  131. GIESE H, Haenig B, Haenig A, Unterberg A, et al
    Neurological and neuropsychological outcome after resection of craniopharyngiomas.
    J Neurosurg. 2019 Apr 19:1-10. doi: 10.3171/2018.10.JNS181557.
    PubMed     Abstract available

  132. ULGEN E, Can O, Bilguvar K, Oktay Y, et al
    Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
    J Neurosurg. 2019 Apr 5:1-12. doi: 10.3171/2019.1.JNS182938.
    PubMed     Abstract available

  133. PRZYBYLOWSKI CJ, Baranoski JF, So VM, Wilson J, et al
    Surgical morbidity of transsylvian versus transcortical approaches to insular gliomas.
    J Neurosurg. 2019 Apr 5:1-8. doi: 10.3171/2018.12.JNS183075.
    PubMed     Abstract available

  134. LIN Z, Jiang Z
    Erratum. Clinical characteristics of and treatment protocol for trapped temporal horn following resection of lateral ventricular trigone meningioma: a single-center experience.
    J Neurosurg. 2019 Apr 5:1. doi: 10.3171/2019.3.JNS182710.

  135. HAN EY, Wang H, Luo D, Li J, et al
    Dosimetric comparison of fractionated radiosurgery plans using frameless Gamma Knife ICON and CyberKnife systems with linear accelerator-based radiosurgery plans for multiple large brain metastases.
    J Neurosurg. 2019 Apr 5:1-7. doi: 10.3171/2019.1.JNS182769.
    PubMed     Abstract available

  136. DALLE ORE CL, Magill ST, Yen AJ, Shahin MN, et al
    Meningioma metastases: incidence and proposed screening paradigm.
    J Neurosurg. 2019 Apr 5:1-9. doi: 10.3171/2019.1.JNS181771.
    PubMed     Abstract available

  137. HANALIOGLU S, Sahin B, Sahin OS, Kozan A, et al
    Effect of perioperative aspirin use on hemorrhagic complications in elective craniotomy for brain tumors: results of a single-center, retrospective cohort study.
    J Neurosurg. 2019 Apr 5:1-10. doi: 10.3171/2018.12.JNS182483.
    PubMed     Abstract available

    March 2019
  138. WILDE H, Azab MA, Abunimer AM, Abou-Al-Shaar H, et al
    Evaluation of cost and survival in intracranial gliomas using the Value Driven Outcomes database: a retrospective cohort analysis.
    J Neurosurg. 2019 Mar 29:1-11. doi: 10.3171/2018.12.JNS183109.
    PubMed     Abstract available

  139. CHOI BD, Lee DK, Yang JC, Ayinon CM, et al
    Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.
    J Neurosurg. 2019 Mar 29:1-7. doi: 10.3171/2018.12.JNS182700.
    PubMed     Abstract available

  140. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas in the precentral gyrus: utility for predicting motor function.
    J Neurosurg. 2019 Mar 15:1-11. doi: 10.3171/2018.11.JNS182609.
    PubMed     Abstract available

  141. WANG W, Swenson S, Cho HY, Hofman FM, et al
    Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models.
    J Neurosurg. 2019 Mar 15:1-9. doi: 10.3171/2018.11.JNS181161.
    PubMed     Abstract available

  142. ROH TH, Kang SG, Moon JH, Sung KS, et al
    Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.
    J Neurosurg. 2019 Mar 1:1-7. doi: 10.3171/2018.12.JNS182558.
    PubMed     Abstract available

  143. SHAFIQ AR, Wernicke AG, Riley CA, Morgenstern PF, et al
    Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.
    J Neurosurg. 2019 Mar 1:1-6. doi: 10.3171/2018.11.JNS181943.
    PubMed     Abstract available

    February 2019
  144. SINGH C, Qian JM, Yu JB, Chiang VL, et al
    Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    J Neurosurg. 2019 Feb 15:1-6. doi: 10.3171/2018.10.JNS181371.
    PubMed     Abstract available

  145. ZHU P, Du XL, Zhu JJ, Esquenazi Y, et al
    Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
    J Neurosurg. 2019 Feb 15:1-12. doi: 10.3171/2018.10.JNS182247.
    PubMed     Abstract available

  146. GOZAL YM, Alzhrani G, Abou-Al-Shaar H, Azab MA, et al
    Outcomes of decompressive surgery for cavernous sinus meningiomas: long-term follow-up in 50 patients.
    J Neurosurg. 2019 Feb 15:1-8. doi: 10.3171/2018.10.JNS181480.
    PubMed     Abstract available

  147. LIN Z, Wang C, Gao Z, Li X, et al
    Clinical characteristics of and treatment protocol for trapped temporal horn following resection of lateral ventricular trigone meningioma: a single-center experience.
    J Neurosurg. 2019 Feb 15:1-10. doi: 10.3171/2018.11.JNS182710.
    PubMed     Abstract available

  148. PARSAI S, Miller JA, Juloori A, Chao ST, et al
    Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    J Neurosurg. 2019 Feb 8:1-9. doi: 10.3171/2018.10.JNS182340.
    PubMed     Abstract available

  149. KATSEVMAN GA, Turner RC, Urhie O, Voelker JL, et al
    Utility of sodium fluorescein for achieving resection targets in glioblastoma: increased gross- or near-total resections and prolonged survival.
    J Neurosurg. 2019 Feb 8:1-7. doi: 10.3171/2018.10.JNS181174.
    PubMed     Abstract available

  150. BO HK, Solheim O, Kvistad KA, Berntsen EM, et al
    Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    J Neurosurg. 2019 Feb 1:1-12. doi: 10.3171/2018.10.JNS181290.
    PubMed     Abstract available

  151. KO CC, Chen TY, Lim SW, Kuo YT, et al
    Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
    J Neurosurg. 2019 Feb 1:1-9. doi: 10.3171/2018.10.JNS181783.
    PubMed     Abstract available

    January 2019
  152. WHITING BB, Lee BS, Mahadev V, Borghei-Razavi H, et al
    Combined use of minimal access craniotomy, intraoperative magnetic resonance imaging, and awake functional mapping for the resection of gliomas in 61 patients.
    J Neurosurg. 2019 Jan 25:1-9. doi: 10.3171/2018.9.JNS181802.
    PubMed     Abstract available

  153. MINCHEV G, Kronreif G, Ptacek W, Dorfer C, et al
    A novel robot-guided minimally invasive technique for brain tumor biopsies.
    J Neurosurg. 2019 Jan 18:1-9. doi: 10.3171/2018.8.JNS182096.
    PubMed     Abstract available

  154. JULOORI A, Miller JA, Parsai S, Kotecha R, et al
    Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
    J Neurosurg. 2019 Jan 18:1-9. doi: 10.3171/2018.8.JNS182100.
    PubMed     Abstract available

  155. RUTLAND JW, Padormo F, Yim CK, Yao A, et al
    Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
    J Neurosurg. 2019 Jan 18:1-10. doi: 10.3171/2018.9.JNS182022.
    PubMed     Abstract available

  156. WAGNER A, Shiban Y, Lange N, Joerger AK, et al
    The relevant psychological burden of having a benign brain tumor: a prospective study of patients undergoing surgical treatment of cranial meningiomas.
    J Neurosurg. 2019 Jan 11:1-8. doi: 10.3171/2018.8.JNS181343.
    PubMed     Abstract available

  157. CHEN CH, Chen PY, Lin YY, Feng LY, et al
    Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma.
    J Neurosurg. 2019 Jan 11:1-12. doi: 10.3171/2018.8.JNS181217.
    PubMed     Abstract available

  158. ALFARO CM, Pirro V, Keating MF, Hattab EM, et al
    Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.
    J Neurosurg. 2019 Jan 4:1-8. doi: 10.3171/2018.8.JNS181207.
    PubMed     Abstract available

  159. RINALDO L, Brown DA, Bhargav AG, Rusheen AE, et al
    Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    J Neurosurg. 2019 Jan 4:1-12. doi: 10.3171/2018.7.JNS181175.
    PubMed     Abstract available

  160. HERVEY-JUMPER SL, Berger MS
    Insular glioma surgery: an evolution of thought and practice.
    J Neurosurg. 2019;130:9-16.
    PubMed     Abstract available

    December 2018
  161. SHEEHAN JP, Grills I, Chiang VL, Dong H, et al
    Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
    J Neurosurg. 2018 Dec 21:1-7. doi: 10.3171/2018.8.JNS181599.
    PubMed     Abstract available

  162. TAKAMI H, Prummer CM, Graffeo CS, Peris-Celda M, et al
    Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: case report.
    J Neurosurg. 2018 Dec 21:1-5. doi: 10.3171/2018.8.JNS181702.
    PubMed     Abstract available

  163. BRACHMAN DG, Youssef E, Dardis CJ, Sanai N, et al
    Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    J Neurosurg. 2018 Dec 21:1-10. doi: 10.3171/2018.7.JNS18656.
    PubMed     Abstract available

  164. MUNIER SM, Hargreaves EL, Patel NV, Danish SF, et al
    Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy.
    J Neurosurg. 2018 Dec 21:1-8. doi: 10.3171/2018.7.JNS18886.
    PubMed     Abstract available

  165. Prospective clinical validation of a meningioma consistency grading scheme: association with surgical outcomes and extent of tumor resection.
    J Neurosurg. 2018 Dec 14:1-5. doi: 10.3171/2018.7.JNS1838.
    PubMed     Abstract available

  166. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
    J Neurosurg. 2018 Dec 14:1-8. doi: 10.3171/2018.7.JNS181293.
    PubMed     Abstract available

  167. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.
    J Neurosurg. 2018 Dec 14:1-11. doi: 10.3171/2018.7.JNS181642.
    PubMed     Abstract available

  168. Letter to the Editor. Preoperative seizures as predictive sign of brain invasion by meningioma.
    J Neurosurg. 2018 Dec 1:1-3. doi: 10.3171/2018.10.JNS182851.

  169. Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma.
    J Neurosurg. 2018 Dec 1:1-8. doi: 10.3171/2018.7.JNS18422.
    PubMed     Abstract available

  170. Pretreatment texture analysis of routine MR images and shape analysis of the diffusion tensor for prediction of volumetric response after radiosurgery for meningioma.
    J Neurosurg. 2018;129.
    PubMed     Abstract available

  171. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
    J Neurosurg. 2018;129.
    PubMed     Abstract available

  172. Hearing preservation after Gamma Knife radiosurgery for cerebellopontine angle meningiomas.
    J Neurosurg. 2018;129.
    PubMed     Abstract available

  173. Three-stage Gamma Knife treatment for metastatic brain tumors larger than 10 cm3: a 2-institute study including re-analyses of earlier results using competing risk analysis.
    J Neurosurg. 2018;129.
    PubMed     Abstract available

  174. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    J Neurosurg. 2018;129.
    PubMed     Abstract available

    November 2018

  175. Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas.
    J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18901.
    PubMed     Abstract available

  176. Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results.
    J Neurosurg. 2018 Nov 1:1-11. doi: 10.3171/2018.5.JNS18198.
    PubMed     Abstract available

  177. Surgical outcomes after reoperation for recurrent non-skull base meningiomas.
    J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18118.
    PubMed     Abstract available

  178. Survival effects of a strategy favoring second-line multimodal treatment compared to supportive care in glioblastoma patients at first progression.
    J Neurosurg. 2018 Nov 1:1-6. doi: 10.3171/2018.7.JNS18228.
    PubMed     Abstract available

    October 2018

  179. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18153.
    PubMed     Abstract available

  180. Harvey Cushing's craniopharyngioma treatment: Part 2. Surgical strategies and results of his pioneering series.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18154.
    PubMed     Abstract available

  181. Transcortical insular glioma resection: clinical outcome and predictors.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS18424.
    PubMed     Abstract available

  182. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    J Neurosurg. 2018 Oct 1:1-7. doi: 10.3171/2018.5.JNS18340.
    PubMed     Abstract available

  183. A modern series of subdiaphragmatic craniopharyngiomas.
    J Neurosurg. 2018 Oct 1:1-6. doi: 10.3171/2018.4.JNS172330.
    PubMed     Abstract available

  184. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS172909.
    PubMed     Abstract available

  185. ReStNeuMap: a tool for automatic extraction of resting-state functional MRI networks in neurosurgical practice.
    J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.4.JNS18474.
    PubMed     Abstract available

    September 2018
  186. LAVRADOR JP, Acharya S, Giamouriadis A, Vergani F, et al
    Letter to the Editor. Intermediate-risk meningioma and NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 28:1-3. doi: 10.3171/2018.4.JNS18811.

  187. PUGLISI G, Sciortino T, Rossi M, Leonetti A, et al
    Preserving executive functions in nondominant frontal lobe glioma surgery: an intraoperative tool.
    J Neurosurg. 2018 Sep 28:1-7. doi: 10.3171/2018.4.JNS18393.
    PubMed     Abstract available

  188. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    Perioperative outcomes following reoperation for recurrent insular gliomas.
    J Neurosurg. 2018 Sep 21:1-7. doi: 10.3171/2018.4.JNS18375.
    PubMed     Abstract available

  189. RASSI MS, Prasad S, Can A, Pravdenkova S, et al
    Prognostic factors in the surgical treatment of intracanalicular primary optic nerve sheath meningiomas.
    J Neurosurg. 2018 Sep 21:1-8. doi: 10.3171/2018.4.JNS173080.
    PubMed     Abstract available

  190. HIRATA T, Kinoshita M, Tamari K, Seo Y, et al
    (11)C-methionine-(18)F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    J Neurosurg. 2018 Sep 21:1-11. doi: 10.3171/2018.4.JNS1859.
    PubMed     Abstract available

  191. MUHLESTEIN WE, Akagi DS, McManus AR, Chambless LB, et al
    Machine learning ensemble models predict total charges and drivers of cost for transsphenoidal surgery for pituitary tumor.
    J Neurosurg. 2018 Sep 21:1-10. doi: 10.3171/2018.4.JNS18306.
    PubMed     Abstract available

  192. SUNDBLOM J, Nowinski D, Casar-Borota O, Ryttlefors M, et al
    Removal of giant intraosseous meningioma followed by cranioplasty using a custom-made bioceramic implant: case report.
    J Neurosurg. 2018 Sep 14:1-5. doi: 10.3171/2018.4.JNS1850.
    PubMed     Abstract available

  193. FOLARON M, Strawbridge R, Samkoe KS, Filan C, et al
    Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    J Neurosurg. 2018 Sep 7:1-11. doi: 10.3171/2018.4.JNS172644.
    PubMed     Abstract available

  194. SERIZAWA T, Higuchi Y, Yamamoto M, Matsunaga S, et al
    Comparison of treatment results between 3- and 2-stage Gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study.
    J Neurosurg. 2018 Sep 7:1-11. doi: 10.3171/2018.4.JNS172596.
    PubMed     Abstract available

  195. Erratum. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 1:1. doi: 10.3171/2018.8.JNS161170.

    August 2018
  196. JENKINSON MD, Weber DC, Haylock BJ, Sherratt FC, et al
    Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma.
    J Neurosurg. 2018 Aug 17:1-2. doi: 10.3171/2018.6.JNS181418.

  197. HAN SJ, Morshed RA, Troncon I, Jordan KM, et al
    Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases.
    J Neurosurg. 2018 Aug 17:1-8. doi: 10.3171/2018.3.JNS172494.
    PubMed     Abstract available

  198. BROKINKEL B, Sicking J, Spille DC, Hess K, et al
    Letter to the Editor. Brain invasion and the risk for postoperative hemorrhage and neurological deterioration after meningioma surgery.
    J Neurosurg. 2018 Aug 10:1-3. doi: 10.3171/2018.5.JNS181287.

  199. MASUDA Y, Akutsu H, Ishikawa E, Matsuda M, et al
    Evaluation of the extent of resection and detection of ischemic lesions with intraoperative MRI in glioma surgery: is intraoperative MRI superior to early postoperative MRI?
    J Neurosurg. 2018 Aug 10:1-8. doi: 10.3171/2018.3.JNS172516.
    PubMed     Abstract available

  200. HARA T, Akutsu H, Takano S, Kino H, et al
    Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.
    J Neurosurg. 2018 Aug 3:1-10. doi: 10.3171/2018.3.JNS172528.
    PubMed     Abstract available

  201. Erratum. A prospective randomized trial of the optimal dose of mannitol for intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018;129:551-552.

    July 2018
  202. SCHERER M, Jungk C, Gotz M, Kickingereder P, et al
    Early postoperative delineation of residual tumor after low-grade glioma resection by probabilistic quantification of diffusion-weighted imaging.
    J Neurosurg. 2018 Jul 27:1-9. doi: 10.3171/2018.2.JNS172951.
    PubMed     Abstract available

  203. PARK KJ, Kano H, Iyer A, Liu X, et al
    Gamma Knife stereotactic radiosurgery for cavernous sinus meningioma: long-term follow-up in 200 patients.
    J Neurosurg. 2018 Jul 20:1-10. doi: 10.3171/2018.2.JNS172361.
    PubMed     Abstract available

    June 2018
  204. LAGMAN C, Ong V, Nguyen T, Alkhalid Y, et al
    The Meningioma Vascularity Index: a volumetric analysis of flow voids to predict intraoperative blood loss in nonembolized meningiomas.
    J Neurosurg. 2018 Jun 22:1-6. doi: 10.3171/2018.1.JNS172724.
    PubMed     Abstract available

  205. INCEKARA F, Satoer D, Visch-Brink E, Vincent A, et al
    Changes in language white matter tract microarchitecture associated with cognitive deficits in patients with presumed low-grade glioma.
    J Neurosurg. 2018 Jun 8:1-9. doi: 10.3171/2017.12.JNS171681.
    PubMed     Abstract available

  206. HIDALGO ET, McQuinn MW, Wisoff JH
    Regression after subtotal resection of an optic pathway glioma in an adult without adjuvant therapy: case report.
    J Neurosurg. 2018 Jun 1:1-4. doi: 10.3171/2017.12.JNS172188.
    PubMed     Abstract available

  207. KONG B, Liu Y
    Letter to the Editor. How to provide intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018 Jun 1:1-2. doi: 10.3171/2017.8.JNS172025.

    May 2018
  208. OTTENHAUSEN M, Rumalla K, Younus I, Minkowitz S, et al
    Predictors of postoperative motor function in rolandic meningiomas.
    J Neurosurg. 2018 May 25:1-6. doi: 10.3171/2017.12.JNS172423.
    PubMed     Abstract available

  209. AGARWAL N, Gupta D
    Letter to the Editor. Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas: unanswered questions.
    J Neurosurg. 2018 May 25:1-2. doi: 10.3171/2018.3.JNS18598.

  210. MARX S, Schroeder HWS
    Letter to the Editor. Transcranial versus endonasal approaches in tuberculum sellae meningioma surgery.
    J Neurosurg. 2018 May 25:1-2. doi: 10.3171/2018.2.JNS18282.

  211. KIM KH, Kang SJ, Choi JW, Kong DS, et al
    Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention.
    J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.12.JNS171943.
    PubMed     Abstract available

  212. KONG DS, Hong CK, Hong SD, Nam DH, et al
    Selection of endoscopic or transcranial surgery for tuberculum sellae meningiomas according to specific anatomical features: a retrospective multicenter analysis (KOSEN-002).
    J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.11.JNS171337.
    PubMed     Abstract available

  213. LIN M, Wedemeyer MA, Bradley D, Donoho DA, et al
    Long-term surgical outcomes following transsphenoidal surgery in patients with Rathke's cleft cysts.
    J Neurosurg. 2018 May 18:1-7. doi: 10.3171/2017.11.JNS171498.
    PubMed     Abstract available

  214. PRIETO R, Pascual JM, Barrios L
    Letter to the Editor. The role of preoperative MRI in predicting craniopharyngioma behavior.
    J Neurosurg. 2018 May 4:1-3. doi: 10.3171/2017.11.JNS172880.

  215. AHLUWALIA M, Barnett GH, Deng D, Tatter SB, et al
    Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
    J Neurosurg. 2018 May 4:1-8. doi: 10.3171/2017.11.JNS171273.
    PubMed     Abstract available

  216. MAGILL ST, Lee DS, Yen AJ, Lucas CG, et al
    Surgical outcomes after reoperation for recurrent skull base meningiomas.
    J Neurosurg. 2018 May 4:1-8. doi: 10.3171/2017.11.JNS172278.
    PubMed     Abstract available

  217. LIOUTA E, Stranjalis G, Kalyvas AV, Koutsarnakis C, et al
    Parietal association deficits in patients harboring parietal lobe gliomas: a prospective study.
    J Neurosurg. 2018 May 4:1-7. doi: 10.3171/2017.12.JNS171799.
    PubMed     Abstract available

  218. YAMASHITA S, Yokogami K, Matsumoto F, Saito K, et al
    MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
    J Neurosurg. 2018 May 4:1-9. doi: 10.3171/2017.11.JNS171710.
    PubMed     Abstract available

  219. WANG Z, Xing B
    Letter to the Editor. Detection of MRI-negative Cushing's disease by FLAIR imaging: is it reliable?
    J Neurosurg. 2018 May 4:1-2. doi: 10.3171/2017.12.JNS173041.

    April 2018
  220. HIMES BT, Ruff MW, Van Gompel JJ, Park SS, et al
    Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report.
    J Neurosurg. 2018 Apr 27:1-5. doi: 10.3171/2017.11.JNS172373.
    PubMed     Abstract available

  221. LIU F, Chen W, Chen J
    Letter to the Editor. Resection for WHO Grade III gliomas.
    J Neurosurg. 2018 Apr 27:1-2. doi: 10.3171/2017.10.JNS172459.

  222. HESS K, Spille DC, Adeli A, Sporns PB, et al
    Brain invasion and the risk of seizures in patients with meningioma.
    J Neurosurg. 2018 Apr 27:1-8. doi: 10.3171/2017.11.JNS172265.
    PubMed     Abstract available

  223. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes.
    J Neurosurg. 2018 Apr 20:1-9. doi: 10.3171/2017.10.JNS172055.
    PubMed     Abstract available

  224. JHAVERI J, Chowdhary M, Zhang X, Press RH, et al
    Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.9.JNS171735.
    PubMed     Abstract available

  225. SIVAKUMAR W, Jensen M, Martinez J, Tanana M, et al
    Intravenous acetaminophen for postoperative supratentorial craniotomy pain: a prospective, randomized, double-blinded, placebo-controlled trial.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.10.JNS171464.
    PubMed     Abstract available

  226. VOGELBAUM MA, Brewer C, Barnett GH, Mohammadi AM, et al
    First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.
    J Neurosurg. 2018 Apr 13:1-10. doi: 10.3171/2017.10.JNS171845.
    PubMed     Abstract available

  227. BASHIR A, Brennum J, Broholm H, Law I, et al
    The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[(18)F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    J Neurosurg. 2018 Apr 6:1-14. doi: 10.3171/2017.8.JNS171577.
    PubMed     Abstract available

  228. CHEN WC, Magill ST, Wu A, Vasudevan HN, et al
    Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    J Neurosurg. 2018 Apr 6:1-8. doi: 10.3171/2017.9.JNS171609.
    PubMed     Abstract available

    March 2018
  229. AMELOT A, van Effenterre R, Kalamarides M, Cornu P, et al
    Natural history of cavernous sinus meningiomas.
    J Neurosurg. 2018 Mar 30:1-8. doi: 10.3171/2017.7.JNS17662.
    PubMed     Abstract available

  230. BARZILAI O, Ben Moshe S, Sitt R, Sela G, et al
    Improvement in cognitive function after surgery for low-grade glioma.
    J Neurosurg. 2018 Mar 23:1-9. doi: 10.3171/2017.9.JNS17658.
    PubMed     Abstract available

  231. KARSY M, Guan J, Huang LE
    Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
    J Neurosurg. 2018 Mar 16:1-11. doi: 10.3171/2017.9.JNS172036.
    PubMed     Abstract available

  232. LI D, Jiao YM, Wang L, Lin FX, et al
    Surgical outcome of motor deficits and neurological status in brainstem cavernous malformations based on preoperative diffusion tensor imaging: a prospective randomized clinical trial.
    J Neurosurg. 2018 Mar 16:1-16. doi: 10.3171/2017.8.JNS17854.
    PubMed     Abstract available

  233. KUROGI R, Nakamizo A, Suzuki SO, Mizoguchi M, et al
    Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
    J Neurosurg. 2018 Mar 9:1-12. doi: 10.3171/2017.8.JNS1788.
    PubMed     Abstract available

    February 2018
  234. ROSSI M, Fornia L, Puglisi G, Leonetti A, et al
    Assessment of the praxis circuit in glioma surgery to reduce the incidence of postoperative and long-term apraxia: a new intraoperative test.
    J Neurosurg. 2018 Feb 23:1-11. doi: 10.3171/2017.7.JNS17357.
    PubMed     Abstract available

  235. WANG L, Chen W, Liu F, Zhang LF, et al
    Letter to the Editor. Multiple meningiomas.
    J Neurosurg. 2018 Feb 23:1-2. doi: 10.3171/2017.8.JNS172004.

  236. VAN BAARSEN K, Roth J, Serova N, Packer RJ, et al
    Optic pathway-hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature.
    J Neurosurg. 2018 Feb 9:1-9. doi: 10.3171/2017.8.JNS163085.
    PubMed     Abstract available

    January 2018
  237. SADIK ZHA, Lie ST, Leenstra S, Hanssens PEJ, et al
    Volumetric changes and clinical outcome for petroclival meningiomas after primary treatment with Gamma Knife radiosurgery.
    J Neurosurg. 2018 Jan 26:1-7. doi: 10.3171/2017.7.JNS17380.
    PubMed     Abstract available

  238. LIU F, Chen W, Chen J
    Letter to the Editor. Is there any relationship between estrogen receptor/progesterone receptor status and recurrence of meningioma?
    J Neurosurg. 2018 Jan 26:1-3. doi: 10.3171/2017.9.JNS172219.

  239. XUE FS, Yang GZ, Li HX, Liu YY, et al
    Letter to the Editor. Is preoperative hypoalbuminemia really a risk factor associated with acute kidney injury and mortality after brain tumor surgery?
    J Neurosurg. 2018 Jan 19:1-3. doi: 10.3171/2017.7.JNS171654.

  240. SHAKIR SI, Souhami L, Petrecca K, Mansure JJ, et al
    Prognostic factors for progression in atypical meningioma.
    J Neurosurg. 2018 Jan 19:1-9. doi: 10.3171/2017.6.JNS17120.
    PubMed     Abstract available

  241. SUEHIRO S, Ohnishi T, Yamashita D, Kohno S, et al
    Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
    J Neurosurg. 2018 Jan 19:1-13. doi: 10.3171/2017.6.JNS162398.
    PubMed     Abstract available

  242. LUEDI MM, Singh SK, Mosley JC, Hassan ISA, et al
    Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    J Neurosurg. 2018 Jan 12:1-10. doi: 10.3171/2017.7.JNS17668.
    PubMed     Abstract available

  243. SUERO MOLINA E, Schipmann S, Mueller I, Wolfer J, et al
    Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.
    J Neurosurg. 2018 Jan 12:1-8. doi: 10.3171/2017.7.JNS171312.
    PubMed     Abstract available

  244. PATIBANDLA MR, Lee CC, Tata A, Addagada GC, et al
    Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
    J Neurosurg. 2018 Jan 5:1-11. doi: 10.3171/2017.6.JNS17993.
    PubMed     Abstract available

  245. GOLDMAN DA, Hovinga K, Reiner AS, Esquenazi Y, et al
    The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
    J Neurosurg. 2018 Jan 5:1-9. doi: 10.3171/2017.6.JNS17393.
    PubMed     Abstract available

  246. DIAO K, Bian SX, Routman DM, Yu C, et al
    Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects.
    J Neurosurg. 2018 Jan 5:1-10. doi: 10.3171/2017.7.JNS171286.
    PubMed     Abstract available

    December 2017
  247. SHAN B, Zhang J, Xu J
    Letter to the Editor. Function outcome related to aggressive surgery for meningioma?
    J Neurosurg. 2017 Dec 22:1-2. doi: 10.3171/2017.6.JNS171089.

  248. RINALDO L, Brown D, Lanzino G, Parney IF, et al
    Outcomes following cerebrospinal fluid shunting in high-grade glioma patients.
    J Neurosurg. 2017 Dec 22:1-13. doi: 10.3171/2017.6.JNS17859.
    PubMed     Abstract available

  249. MAYBERG M, Reintjes S, Patel A, Moloney K, et al
    Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    J Neurosurg. 2017 Dec 22:1-10. doi: 10.3171/2017.6.JNS17635.
    PubMed     Abstract available

  250. FERROLI P, Broggi M
    Letter to the Editor. Outcome prediction in brain tumor surgery.
    J Neurosurg. 2017 Dec 15:1-3. doi: 10.3171/2017.5.JNS171098.

  251. PRASAD GL
    Letter to the Editor. Usefulness of 5-ALA in resection of intracranial meningiomas.
    J Neurosurg. 2017 Dec 1:1-3. doi: 10.3171/2017.6.JNS17634.

    Journal of Neurosurgery's Top 25 highly cited articles on Gamma Knife surgery for meningioma.
    J Neurosurg. 2017;127.

    November 2017
  253. SHASBY G
    Erratum. Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases.
    J Neurosurg. 2017 Nov 24:1. doi: 10.3171/2017.8.JNS08268.

  254. YAMAGUCHI F, Ten H, Higuchi T, Omura T, et al
    An intraoperative motor tract positioning method in brain tumor surgery: technical note.
    J Neurosurg. 2017 Nov 24:1-7. doi: 10.3171/2017.5.JNS162978.
    PubMed     Abstract available

  255. NEIL D
    Letter to the Editor. Puzzling posology: was the bevacizumab regimen in recurrent glioblastoma misreported?
    J Neurosurg. 2017 Nov 24:1. doi: 10.3171/2017.5.JNS171208.

  256. OMAY SB, Almeida JP, Chen YN, Shetty SR, et al
    Is the chiasm-pituitary corridor size important for achieving gross-total resection during endonasal endoscopic resection of craniopharyngiomas?
    J Neurosurg. 2017 Nov 24:1-6. doi: 10.3171/2017.6.JNS163188.
    PubMed     Abstract available

  257. MAO L, Whitehead CA, Paradiso L, Kaye AH, et al
    Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
    J Neurosurg. 2017 Nov 17:1-13. doi: 10.3171/2017.5.JNS17845.
    PubMed     Abstract available

  258. SOUTHWELL DG, Birk HS, Han SJ, Li J, et al
    Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.
    J Neurosurg. 2017 Nov 10:1-9. doi: 10.3171/2017.5.JNS17166.
    PubMed     Abstract available

  259. ZHENG SH, Huang JL, Chen M, Wang BL, et al
    Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    J Neurosurg. 2017 Nov 3:1-10. doi: 10.3171/2017.3.JNS161648.
    PubMed     Abstract available

    October 2017
  260. KIESEL B, Mischkulnig M, Woehrer A, Martinez-Moreno M, et al
    Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    J Neurosurg. 2017 Oct 27:1-13. doi: 10.3171/2017.4.JNS162991.
    PubMed     Abstract available

  261. POMERANIEC IJ, Kano H, Xu Z, Nguyen B, et al
    Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    J Neurosurg. 2017 Oct 27:1-10. doi: 10.3171/2017.5.JNS163069.
    PubMed     Abstract available

  262. FIGUEROA JM, Carter BS
    Detection of glioblastoma in biofluids.
    J Neurosurg. 2017 Oct 20:1-7. doi: 10.3171/2017.3.JNS162280.
    PubMed     Abstract available

  263. CHATAIN GP, Patronas N, Smirniotopoulos JG, Piazza M, et al
    Potential utility of FLAIR in MRI-negative Cushing's disease.
    J Neurosurg. 2017 Oct 13:1-9. doi: 10.3171/2017.4.JNS17234.
    PubMed     Abstract available

  264. YUE Q, Yu Y, Shi Z, Wang Y, et al
    Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
    J Neurosurg. 2017 Oct 6:1-8. doi: 10.3171/2017.4.JNS163113.
    PubMed     Abstract available

  265. OPOKU-DARKO M, Lang ST, Artindale J, Cairncross JG, et al
    Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
    J Neurosurg. 2017 Oct 6:1-8. doi: 10.3171/2017.3.JNS17159.
    PubMed     Abstract available

  266. ROGERS L, Zhang P, Vogelbaum MA, Perry A, et al
    Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2017 Oct 6:1-13. doi: 10.3171/2016.11.JNS161170.
    PubMed     Abstract available

    September 2017
  267. ABEL TJ, Barrash J, Tranel D
    Letter to the Editor. Neuropsychological impairment and quality of life after skull base meningioma resection: size and location matter.
    J Neurosurg. 2017 Sep 29:1-2. doi: 10.3171/2017.4.JNS17740.

  268. DHO YS, Kim YH, Se YB, Han DH, et al
    Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
    J Neurosurg. 2017 Sep 29:1-9. doi: 10.3171/2017.4.JNS162143.
    PubMed     Abstract available

  269. ANGELOV L, Mohammadi AM, Bennett EE, Abbassy M, et al
    Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases >/= 2 cm.
    J Neurosurg. 2017 Sep 22:1-17. doi: 10.3171/2017.3.JNS162532.
    PubMed     Abstract available

  270. FUJII Y, Muragaki Y, Maruyama T, Nitta M, et al
    Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    J Neurosurg. 2017 Sep 8:1-9. doi: 10.3171/2017.3.JNS162383.
    PubMed     Abstract available

  271. ALMEIDA JP, Omay SB, Shetty SR, Chen YN, et al
    Transorbital endoscopic eyelid approach for resection of sphenoorbital meningiomas with predominant hyperostosis: report of 2 cases.
    J Neurosurg. 2017 Sep 1:1-11. doi: 10.3171/2017.3.JNS163110.
    PubMed     Abstract available

  272. HIRAYAMA R, Kinoshita M, Arita H, Kagawa N, et al
    Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions.
    J Neurosurg. 2017 Sep 1:1-6. doi: 10.3171/2017.3.JNS17169.
    PubMed     Abstract available

  273. MEHTA GU, Zenonos G, Patibandla MR, Lin CJ, et al
    Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study.
    J Neurosurg. 2017 Sep 1:1-7. doi: 10.3171/2017.3.JNS163008.
    PubMed     Abstract available

    August 2017
  274. ZUBATKINA I, Ivanov P
    Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    J Neurosurg. 2017 Aug 25:1-12. doi: 10.3171/2017.1.JNS162075.
    PubMed     Abstract available

  275. SHAHAR T, Korn A, Barkay G, Biron T, et al
    Elaborate mapping of the posterior visual pathway in awake craniotomy.
    J Neurosurg. 2017 Aug 25:1-9. doi: 10.3171/2017.2.JNS162757.
    PubMed     Abstract available

  276. HUA L, Zhu H, Li J, Tang H, et al
    Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    J Neurosurg. 2017 Aug 18:1-9. doi: 10.3171/2017.2.JNS162566.
    PubMed     Abstract available

  277. BRAGSTAD S, Flatebo M, Natvig GK, Eide GE, et al
    Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    J Neurosurg. 2017 Aug 18:1-13. doi: 10.3171/2017.2.JNS161659.
    PubMed     Abstract available

  278. KALOSHI G, Petrela M
    Letter to the Editor. An extent of resection threshold for recurrent glioblastoma: why wait until recurrence?
    J Neurosurg. 2017 Aug 18:1. doi: 10.3171/2017.6.JNS14868.

  279. KOTECHA R, Miller JA, Venur VA, Mohammadi AM, et al
    Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    J Neurosurg. 2017 Aug 11:1-10. doi: 10.3171/2017.1.JNS162797.
    PubMed     Abstract available

    July 2017
  280. OUSHY S, Sillau SH, Ney DE, Damek DM, et al
    New-onset seizure during and after brain tumor excision: a risk assessment analysis.
    J Neurosurg. 2017 Jul 28:1-6. doi: 10.3171/2017.2.JNS162315.
    PubMed     Abstract available

  281. LAU D, Hervey-Jumper SL, Han SJ, Berger MS, et al
    Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    J Neurosurg. 2017 Jul 21:1-9. doi: 10.3171/2017.1.JNS161811.
    PubMed     Abstract available

  282. PAVLOV V, Varlet P, Chretien F, Nguyen G, et al
    Letter to the Editor. Expression of tissue (pro)renin receptor and concentrations of its soluble form in CSF in adult diffuse gliomas.
    J Neurosurg. 2017 Jul 21:1-3. doi: 10.3171/2017.2.JNS17254.

  283. TSERMOULAS G, Turel MK, Wilcox JT, Shultz D, et al
    Management of multiple meningiomas.
    J Neurosurg. 2017 Jul 21:1-7. doi: 10.3171/2017.2.JNS162608.
    PubMed     Abstract available

  284. ORTON A, Frandsen J, Jensen R, Shrieve DC, et al
    Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
    J Neurosurg. 2017 Jul 21:1-6. doi: 10.3171/2017.2.JNS162282.
    PubMed     Abstract available

  285. OMAY SB, Chen YN, Almeida JP, Ruiz-Trevino AS, et al
    Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    J Neurosurg. 2017 Jul 14:1-6. doi: 10.3171/2017.1.JNS162232.
    PubMed     Abstract available

  286. TURE H, Harput MV, Bekiroglu N, Keskin O, et al
    Effect of the degree of head elevation on the incidence and severity of venous air embolism in cranial neurosurgical procedures with patients in the semisitting position.
    J Neurosurg. 2017 Jul 14:1-10. doi: 10.3171/2017.1.JNS162489.
    PubMed     Abstract available

  287. CONNER AK, Burks JD, Baker CM, Smitherman AD, et al
    Method for temporal keyhole lobectomies in resection of low- and high-grade gliomas.
    J Neurosurg. 2017 Jul 7:1-8. doi: 10.3171/2016.12.JNS162168.
    PubMed     Abstract available

    June 2017
  288. MORSHED RA, Han SJ, Lau D, Berger MS, et al
    Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
    J Neurosurg. 2017 Jun 30:1-6. doi: 10.3171/2017.1.JNS161949.
    PubMed     Abstract available

  289. AKYERLI CB, Yuksel S, Can O, Erson-Omay EZ, et al
    Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    J Neurosurg. 2017 Jun 16:1-13. doi: 10.3171/2016.11.JNS16973.
    PubMed     Abstract available

  290. KIM D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, et al
    Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
    J Neurosurg. 2017 Jun 16:1-10. doi: 10.3171/2016.11.JNS16913.
    PubMed     Abstract available

  291. ESEONU CI, Eguia F, Garcia O, Kaplan PW, et al
    Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
    J Neurosurg. 2017 Jun 16:1-7. doi: 10.3171/2017.1.JNS162913.
    PubMed     Abstract available

  292. SHAH AH, Jusue-Torres I, Ivan ME, Komotar RJ, et al
    Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy.
    J Neurosurg. 2017 Jun 9:1-8. doi: 10.3171/2016.12.JNS162123.
    PubMed     Abstract available

  293. MANDA SV, Kataria Y, Tatireddy BR, Ramakrishnan B, et al
    Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    J Neurosurg. 2017 Jun 2:1-11. doi: 10.3171/2016.11.JNS161187.
    PubMed     Abstract available

    May 2017
  294. XU DS, Awad AW, Mehalechko C, Wilson JR, et al
    An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    J Neurosurg. 2017 May 26:1-7. doi: 10.3171/2016.12.JNS161682.
    PubMed     Abstract available

  295. KIM K, Bang JY, Kim SO, Kim S, et al
    Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study.
    J Neurosurg. 2017 May 5:1-8. doi: 10.3171/2016.11.JNS162237.
    PubMed     Abstract available

  296. REN Q, He M, Xu J
    Letter to the Editor. Does preoperative NLR predict brain metastasis resections outcome?
    J Neurosurg. 2017 May 5. doi: 10.3171/2016.12.JNS163096.

  297. MURATA D, Mineharu Y, Arakawa Y, Liu B, et al
    High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma.
    J Neurosurg. 2017 May 5:1-7. doi: 10.3171/2016.11.JNS16991.
    PubMed     Abstract available

    April 2017
  298. SAITO T, Sugiyama K, Takeshima Y, Amatya VJ, et al
    Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    J Neurosurg. 2017 Apr 21:1-6. doi: 10.3171/2016.11.JNS162326.
    PubMed     Abstract available

  299. COTE DJ, Balak N, Brennum J, Holsgrove DT, et al
    Ethical difficulties in the innovative surgical treatment of patients with recurrent glioblastoma multiforme.
    J Neurosurg. 2017 Apr 21:1-6. doi: 10.3171/2016.11.JNS162488.

  300. WANG W, Cho HY, Rosenstein-Sisson R, Marin Ramos NI, et al
    Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
    J Neurosurg. 2017 Apr 14:1-6. doi: 10.3171/2016.11.JNS161212.
    PubMed     Abstract available

  301. LEE JY, Pierce JT, Thawani JP, Zeh R, et al
    Near-infrared fluorescent image-guided surgery for intracranial meningioma.
    J Neurosurg. 2017 Apr 7:1-11. doi: 10.3171/2016.10.JNS161636.
    PubMed     Abstract available

  302. YAO PS, Zheng SF, Wang F, Kang DZ, et al
    Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
    J Neurosurg. 2017 Apr 7:1-6. doi: 10.3171/2016.11.JNS161296.
    PubMed     Abstract available

  303. MARX S, Clemens S, Schroeder HW
    The value of endoscope assistance during transcranial surgery for tuberculum sellae meningiomas.
    J Neurosurg. 2017 Apr 7:1-8. doi: 10.3171/2016.11.JNS16713.
    PubMed     Abstract available

  304. GESSLER F, Bruder M, Duetzmann S, Tritt S, et al
    Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
    J Neurosurg. 2017 Apr 7:1-7. doi: 10.3171/2016.11.JNS161871.
    PubMed     Abstract available

    March 2017
  305. KARSY M, Burnett B, Di Ieva A, Cusimano MD, et al
    Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
    J Neurosurg. 2017 Mar 31:1-10. doi: 10.3171/2016.10.JNS161825.
    PubMed     Abstract available

  306. THOMAS JG, Parker Kerrigan BC, Hossain A, Gumin J, et al
    Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    J Neurosurg. 2017 Mar 31:1-9. doi: 10.3171/2016.9.JNS16278.
    PubMed     Abstract available

  307. KOLAKSHYAPATI M, Adhikari RB, Karlowee V, Takayasu T, et al
    Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    J Neurosurg. 2017 Mar 31:1-12. doi: 10.3171/2016.10.JNS161694.
    PubMed     Abstract available

  308. TULEASCA C, Negretti L, Faouzi M, Magaddino V, et al
    Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    J Neurosurg. 2017 Mar 24:1-10. doi: 10.3171/2016.10.JNS161480.
    PubMed     Abstract available

  309. COHEN-INBAR O, Tata A, Moosa S, Lee CC, et al
    Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation.
    J Neurosurg. 2017 Mar 24:1-11. doi: 10.3171/2016.11.JNS161402.
    PubMed     Abstract available

  310. SUERO MOLINA E, Wolfer J, Ewelt C, Ehrhardt A, et al
    Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
    J Neurosurg. 2017 Mar 24:1-7. doi: 10.3171/2016.11.JNS161072.
    PubMed     Abstract available

  311. TIETZE A, Choi C, Mickey B, Maher EA, et al
    Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
    J Neurosurg. 2017 Mar 3:1-8. doi: 10.3171/2016.10.JNS161793.
    PubMed     Abstract available

  312. PEETERS S, Pages M, Gauchotte G, Miquel C, et al
    Interactions between glioma and pregnancy: insight from a 52-case multicenter series.
    J Neurosurg. 2017 Mar 3:1-11. doi: 10.3171/2016.10.JNS16710.
    PubMed     Abstract available

  313. FLORMAN JE, Cushing D, Keller LA, Rughani AI, et al
    A protocol for postoperative admission of elective craniotomy patients to a non-ICU or step-down setting.
    J Neurosurg. 2017 Mar 3:1-6. doi: 10.3171/2016.10.JNS16954.
    PubMed     Abstract available

    February 2017
  314. MITTAL S, Klinger NV, Michelhaugh SK, Barger GR, et al
    Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    J Neurosurg. 2017 Feb 24:1-8. doi: 10.3171/2016.9.JNS16452.
    PubMed     Abstract available

  315. MASTORAKOS P, Hays MA, Caruso JP, Chen CJ, et al
    Transtentorial dissemination of optic nerve glioblastoma: case report.
    J Neurosurg. 2017 Feb 17:1-8. doi: 10.3171/2016.10.JNS161443.
    PubMed     Abstract available

  316. WOLF A, Kvint S, Chachoua A, Pavlick A, et al
    Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
    J Neurosurg. 2017 Feb 17:1-9. doi: 10.3171/2016.10.JNS161036.
    PubMed     Abstract available

  317. DENG L, Zhou H, Xiao B, Bai HX, et al
    Letter to the Editor: Specificity and validity of putaminal involvement as a prognostic factor in Grade II insular gliomas.
    J Neurosurg. 2017 Feb 10:1-2. doi: 10.3171/2016.9.JNS162311.

  318. ZWECKBERGER K, Hallek E, Vogt L, Giese H, et al
    Prospective analysis of neuropsychological deficits following resection of benign skull base meningiomas.
    J Neurosurg. 2017 Feb 10:1-7. doi: 10.3171/2016.10.JNS161936.
    PubMed     Abstract available

  319. D'AMICO RS, Banu MA, Petridis P, Bercow AS, et al
    Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas.
    J Neurosurg. 2017 Feb 10:1-11. doi: 10.3171/2016.10.JNS161982.
    PubMed     Abstract available

  320. GATTERBAUER B, Gevsek S, Hoftberger R, Lutgendorf-Caucig C, et al
    Multimodal treatment of parasagittal meningiomas: a single-center experience.
    J Neurosurg. 2017 Feb 3:1-8. doi: 10.3171/2016.9.JNS161859.
    PubMed     Abstract available

    January 2017
  321. BANDER ED, Singh H, Ogilvie CB, Cusic RC, et al
    Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas in a similar cohort of patients.
    J Neurosurg. 2017 Jan 27:1-9. doi: 10.3171/2016.9.JNS16823.
    PubMed     Abstract available

  322. JEHNA M, Becker J, Zaar K, von Campe G, et al
    Symmetry of the arcuate fasciculus and its impact on language performance of patients with brain tumors in the language-dominant hemisphere.
    J Neurosurg. 2017 Jan 27:1-10. doi: 10.3171/2016.9.JNS161281.
    PubMed     Abstract available

  323. CONWAY N, Wildschuetz N, Moser T, Bulubas L, et al
    Cortical plasticity of motor-eloquent areas measured by navigated transcranial magnetic stimulation in patients with glioma.
    J Neurosurg. 2017 Jan 20:1-11. doi: 10.3171/2016.9.JNS161595.
    PubMed     Abstract available

  324. KANO H, Morales-Restrepo A, Iyer A, Weiner GM, et al
    Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
    J Neurosurg. 2017 Jan 20:1-9. doi: 10.3171/2016.9.JNS161011.
    PubMed     Abstract available

  325. LEE EJ, Kim JH, Park ES, Kim YH, et al
    A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas.
    J Neurosurg. 2017 Jan 13:1-10. doi: 10.3171/2016.9.JNS161669.
    PubMed     Abstract available

  326. TAKAKURA T, Muragaki Y, Tamura M, Maruyama T, et al
    Navigated transcranial magnetic stimulation for glioma removal: prognostic value in motor function recovery from postsurgical neurological deficits.
    J Neurosurg. 2017 Jan 6:1-15. doi: 10.3171/2016.8.JNS16442.
    PubMed     Abstract available

  327. COHEN-INBAR O, Shih HH, Xu Z, Schlesinger D, et al
    The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
    J Neurosurg. 2017 Jan 6:1-8. doi: 10.3171/2016.9.JNS161585.
    PubMed     Abstract available

  328. MISSIOS S, Bekelis K
    Emergency department evaluation and 30-day readmission after craniotomy for primary brain tumor resection in New York State.
    J Neurosurg. 2017 Jan 6:1-6. doi: 10.3171/2016.9.JNS161575.
    PubMed     Abstract available

  329. SOUTHWELL DG, Riva M, Jordan K, Caverzasi E, et al
    Language outcomes after resection of dominant inferior parietal lobule gliomas.
    J Neurosurg. 2017 Jan 6:1-9. doi: 10.3171/2016.8.JNS16443.
    PubMed     Abstract available

  330. PRIETO R, Pascual JM
    Norman M. Dott, master of hypothalamic craniopharyngioma surgery: the decisive mentoring of Harvey Cushing and Percival Bailey at Peter Bent Brigham Hospital.
    J Neurosurg. 2017 Jan 6:1-14. doi: 10.3171/2016.9.JNS16702.
    PubMed     Abstract available

  331. BIJANGI-VISHEHSARAEI K, Reza Saadatzadeh M, Wang H, Nguyen A, et al
    Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    J Neurosurg. 2017 Jan 6:1-12. doi: 10.3171/2016.8.JNS161197.
    PubMed     Abstract available

  332. KOUCHI M, Shibayama Y, Ogawa D, Miyake K, et al
    (Pro)renin receptor is crucial for glioma development via the Wnt/beta-catenin signaling pathway.
    J Neurosurg. 2017 Jan 6:1-10. doi: 10.3171/2016.9.JNS16431.
    PubMed     Abstract available

  333. MEIER R, Porz N, Knecht U, Loosli T, et al
    Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
    J Neurosurg. 2017 Jan 6:1-9. doi: 10.3171/2016.9.JNS16146.
    PubMed     Abstract available

  334. MOTOMURA K, Natsume A, Iijima K, Kuramitsu S, et al
    Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.
    J Neurosurg. 2017 Jan 6:1-8. doi: 10.3171/2016.9.JNS16152.
    PubMed     Abstract available

    December 2016
  335. SHRIVASTAVA A, Arora P, Khare A, Goel G, et al
    Central nervous system filariasis masquerading as a glioma: case report.
    J Neurosurg. 2016 Dec 23:1-3. doi: 10.3171/2016.9.JNS161092.
    PubMed     Abstract available

    Letter to the Editor: Recurrent or residual craniopharyngioma: management options.
    J Neurosurg. 2016 Dec 23:1. doi: 10.3171/2016.9.JNS162481.

  337. GRAILLON T, Romano D, Defilles C, Saveanu A, et al
    Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review.
    J Neurosurg. 2016.
    PubMed     Abstract available

  338. RAHEJA A, Colman H, Palmer CA, Couldwell WT, et al
    Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.
    J Neurosurg. 2016.
    PubMed     Abstract available

  339. CHEN YR, Ugiliweneza B, Burton E, Woo SY, et al
    The effect of postoperative infection on survival in patients with glioblastoma.
    J Neurosurg. 2016.
    PubMed     Abstract available

  340. SERIZAWA T, Higuchi Y, Nagano O, Matsuda S, et al
    Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
    J Neurosurg. 2016.
    PubMed     Abstract available

  341. MITSUYA K, Nakasu Y, Kurakane T, Hayashi N, et al
    Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    J Neurosurg. 2016.
    PubMed     Abstract available

  342. DONG P, Perez-Andujar A, Pinnaduwage D, Braunstein S, et al
    Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  343. DUMA CM, Kim BS, Chen PV, Plunkett ME, et al
    Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  344. LESTER-COLL NH, Dosoretz AP, Magnuson WJ, Laurans MS, et al
    Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  345. SPECKTER H, Bido J, Hernandez G, Mejia DR, et al
    Prognostic value of diffusion tensor imaging parameters for Gamma Knife radiosurgery in meningiomas.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  346. VALERY CA, Faillot M, Lamproglou I, Golmard JL, et al
    Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  347. MIX M, Elmarzouky R, O'Connor T, Plunkett R, et al
    Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  348. EL-SHEHABY AM, Reda WA, Abdel Karim KM, Emad Eldin RM, et al
    Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  349. BIAN SX, Routman D, Liu J, Yang D, et al
    Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  350. KAWABE T, Yamamoto M, Sato Y, Yomo S, et al
    Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    J Neurosurg. 2016;125.
    PubMed     Abstract available

  351. KOISO T, Yamamoto M, Kawabe T, Watanabe S, et al
    Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
    J Neurosurg. 2016;125.
    PubMed     Abstract available

    November 2016
  352. STRICKLAND MR, Gill CM, Nayyar N, D'Andrea MR, et al
    Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.
    J Neurosurg. 2016.
    PubMed     Abstract available

  353. JOHN JK, Robin AM, Pabaney AH, Rammo RA, et al
    Complications of ventricular entry during craniotomy for brain tumor resection.
    J Neurosurg. 2016.
    PubMed     Abstract available

    October 2016
  354. ZHANG JT
    Erratum: Foramen magnum meningiomas: surgical results and risks predicting poor outcomes based on a modified classification.
    J Neurosurg. 2016.

  355. BETTE S, Gempt J, Huber T, Delbridge C, et al
    FLAIR signal increase of the fluid within the resection cavity after glioma surgery: generally valid as early recurrence marker?
    J Neurosurg. 2016.
    PubMed     Abstract available

  356. VAIOS EJ, Nahed BV, Muzikansky A, Fathi AT, et al
    Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.
    J Neurosurg. 2016.
    PubMed     Abstract available

  357. NEIRA JA, Ung TH, Sims JS, Malone HR, et al
    Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    J Neurosurg. 2016.
    PubMed     Abstract available

  358. CHERNOV M
    Letter to the Editor: Seizures and invasive meningiomas.
    J Neurosurg. 2016.

  359. WOLF A, Coros A, Bierer J, Goncalves S, et al
    Quantitative evaluation of vision-related and health-related quality of life after endoscopic transsphenoidal surgery for pituitary adenoma.
    J Neurosurg. 2016.
    PubMed     Abstract available

    September 2016
  360. RAHMAN M, Abbatematteo J, De Leo EK, Kubilis PS, et al
    The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    J Neurosurg. 2016.
    PubMed     Abstract available

  361. AZARNOUSH H, Siar S, Sawaya R, Zhrani GA, et al
    The force pyramid: a spatial analysis of force application during virtual reality brain tumor resection.
    J Neurosurg. 2016.
    PubMed     Abstract available

  362. BURKS JD, Bonney PA, Conner AK, Glenn CA, et al
    A method for safely resecting anterior butterfly gliomas: the surgical anatomy of the default mode network and the relevance of its preservation.
    J Neurosurg. 2016.
    PubMed     Abstract available

  363. BANSAL A, Sinha S
    Letter to the Editor: Resection of olfactory groove meningiomas.
    J Neurosurg. 2016.

  364. BAGSHAW HP, Burt LM, Jensen RL, Suneja G, et al
    Adjuvant radiotherapy for atypical meningiomas.
    J Neurosurg. 2016.
    PubMed     Abstract available

    May 2016
  365. KRISHT KM, Palmer CA, Couldwell WT
    Multiple osteomas of the falx cerebri and anterior skull base: case report.
    J Neurosurg. 2016;124:1339-42.
    PubMed     Abstract available

  366. ZOU Z, Yin Y, Lin J, Hsu LC, et al
    Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3.
    J Neurosurg. 2016;124:1310-8.
    PubMed     Abstract available

  367. FAUST K, Vajkoczy P
    Distinct displacements of the optic radiation based on tumor location revealed using preoperative diffusion tensor imaging.
    J Neurosurg. 2016;124:1343-52.
    PubMed     Abstract available

    March 2016
  368. LITTLE AS, Kelly DF, Barkhoudarian G
    Letter to the Editor: Transsphenoidal surgery for nonfunctioning adenomas.
    J Neurosurg. 2016.

  369. TAMURA Y, Ogawa H, Kapeller C, Prueckl R, et al
    Passive language mapping combining real-time oscillation analysis with cortico-cortical evoked potentials for awake craniotomy.
    J Neurosurg. 2016.
    PubMed     Abstract available

  370. MOON JH, Kim EH, Kim SH
    Snare technique for the remodeling of the redundant arachnoid pouch to prevent cerebrospinal fluid rhinorrhea and hematoma collection during transsphenoidal surgery for suprasellar-extended pituitary tumors.
    J Neurosurg. 2016.
    PubMed     Abstract available

    December 2015
  371. PLEDGER CL, Elzoghby MA, Oldfield EH, Payne SC, et al
    Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas.
    J Neurosurg. 2015.
    PubMed     Abstract available

    November 2015
  372. TERPOLILLI NA, Rachinger W, Kunz M, Thon N, et al
    Orbit-associated tumors: navigation and control of resection using intraoperative computed tomography.
    J Neurosurg. 2015.
    PubMed     Abstract available

  373. SOUTHWELL DG, Hervey-Jumper SL, Perry DW, Berger MS, et al
    Intraoperative mapping during repeat awake craniotomy reveals the functional plasticity of adult cortex.
    J Neurosurg. 2015.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.